Dr. Geetika Sabharwal has been honored with a 2025 Global Recognition Award for her sustained contributions to allergy and ...
Cookie dough containing peanuts has been distributed in packages for a different type of cookie dough that does not contain ...
Researchers have found in pediatric sesame oral food challenges (OFCs) that tahini was associated with lower reaction ...
An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...
GSK plc GSK announced that it has entered into a definitive agreement to acquire California-based biotech RAPT Therapeutics ...
Early-life bifidobacteria producing aromatic lactates were linked to lower allergy risk in children. Learn how early ...
GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies.
Britain's GSK is set to acquire RAPT Therapeutics for $2.2 billion. This move brings the experimental food allergy drug ...
The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in ...
There are currently "several serious data gaps" limiting the FDA's ability to know the adverse reactions to gluten in ...
The Daily Overview on MSN
GSK grabs RAPT for $2.2B in big bet on food allergy drugs
GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...
The mechanism underlying how seasonal allergies recur year after year with precise timing remains largely unknown. An international team led by Professor Rudolf Valenta has identified a specific type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback